This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers.
The scientific program consists of formal lectures by experts in clinical, translational, and basic research, selected slide and poster presentations, forums and case discussions. The official language of the symposium is English. Simultaneous translation is not provided.
Event Details
December 9, 2025.
San Antonio, Texas
